Michael Schindelar

Michael Schindelar serves as the Sr. Director Development Asset Lead at Biogen since October 2008, where accountability includes providing strategic drug development expertise and leading asset teams to implement integrated development plans. Prior roles at Biogen include Senior Director R&D Program Lead, where responsibilities encompassed overall R&D strategy and governance, and various leadership positions focusing on clinical operations and program management. Michael's earlier experience includes a Senior Manager role at Ophthalmic Research Associates, overseeing global operations. Academic qualifications include an MBA in Health Sector Management from Boston University and a BS in Physics and Biology from Bowdoin College.